Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

about

Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis.

P2860

Q38644674-F40EF0FB-B559-4414-A55C-713158B58C6D Q50147547-59341BF5-B249-4280-A1BB-E4E75B95390F

P2860

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

Item

http://www.wikidata.org/entity/Q39394485

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@en

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@nl

type

Item

label

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@en

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@nl

prefLabel

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@en

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@nl

P1476

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

@en

P2093

Andrei V Alexandrov

http://www.w3.org/2001/XMLSchema#string

Georgios Tsivgoulis

http://www.w3.org/2001/XMLSchema#string

Odysseas Kargiotis

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis

The fate of medications evaluated for ischemic stroke pharmacotherapy over the period 1995-2015

Cincinnati Prehospital Stroke Scale: reproducibility and validity

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

P304

819-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737175.2017.1347039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28644924

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

about

P2860

P2860

Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921